Apple’s Big Glowtime Event… And Brian Niccol Takes The Wheel At Starbucks 9/9/24
CNBC's "Fast Money"
00:00
Summit Therapeutics: Emerging Competition for Merck
This chapter examines the strong stock market performance of Summit Therapeutics following promising results from a lung cancer drug trial, positioning it as a competitor to Merck's Keytruda. The discussion also explores Merck's financial reliance on Keytruda and the potential push for strategic mergers and acquisitions in the evolving pharmaceutical landscape.
Transcript
Play full episode
